April 10, 2023
The University Report Card uses publicly-available data and university self-reported information to evaluate five key questions:
How and in what ways are universities investing in innovative biomedical research that addresses the neglected health needs of low- and middle-income countries (LMICs)?
When universities license their medical breakthroughs for commercial development, are they doing so in ways that ensure equitable access for people in low and middle income countries? Will these innovative treatments be made available at affordable prices?
Are universities empowering the next generation of global health leaders by educating them on the crucial impact that academic institutions can have on global health and access to medicines through their biomedical research and licensing activities?
How are universities promoting transparency in clinical trial results and academic medical publications?
Have universities committed to sharing the intellectual property, knowledge and data from their COVID-19 research in a way that makes these innovations globally accessible, particularly to people in LMICs?
